Gene Biotherapeutics, Inc. CRXM
0.00 0.00
Day range unavailable
52-week range unavailable
Revenue & Expenses
Latest period ending Dec 31, 2020 · select a line to chart its full history
Annual income statement
| Fiscal year | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 | FY 2018 Dec 31, 2018 | FY 2017 Dec 31, 2017 | FY 2016 Dec 31, 2016 |
|---|---|---|---|---|---|
| 1.26M | 837.00K | 513.23K | 2.08M | 2.84M | |
| 217.58K | 243.45K | 255.39K | 344.98K | 641.57K | |
| 1.04M | 593.55K | 907.84K | 1.78M | 2.20M | |
| -1.26M | -837.00K | -513.23K | -2.08M | -2.84M | |
| 57.40K | 43.79K | 39.51K | 20.22K | 172.82K | |
| -517.90K | 866.67K | -434.88K | -1.89M | -2.92M | |
| -517.90K | 866.67K | -434.88K | -1.89M | -3.70M | |
| -517.90K | 866.67K | -434.88K | -1.89M | -3.70M | |
| -651.55K | 779.13K | -552.74K | -2.10M | -3.01M | |
| -133.65K | -87.55K | -117.86K | -202.36K | -95.58K | |
| -0.02 | 0.05 | -0.03 | -0.13 | -0.28 | |
| -0.02 | 0.05 | -0.03 | -0.13 | -0.28 | |
| -0.02 | 0.05 | -0.03 | -0.13 | -0.28 | |
| -460.50K | 910.46K | -395.37K | -1.87M | -2.75M | |
| -460.50K | 910.46K | -395.37K | -1.87M | -2.75M | |
| 24.12M | 14.49M | 14.42M | 14.29M | 13.33M | |
| 24.12M | 14.49M | 14.42M | 14.29M | 13.33M |